Search

Walter Messier Phones & Addresses

  • 1586 Goshawk Dr, Longmont, CO 80501 (303) 682-9675
  • 2418 Bowen St, Longmont, CO 80501 (303) 682-9675
  • Clifton Park, NY
  • Highland, NY

Work

Position: Clerical/White Collar

Education

Degree: Graduate or professional degree

Professional Records

License Records

Walter Messier

Address:
Clifton Park, NY 12065
License #:
4392 - Expired
Issued Date:
Sep 3, 1986
Expiration Date:
May 22, 1997
Type:
Dispensing Optician

Resumes

Resumes

Walter Messier Photo 1

Chief Science Officer

View page
Location:
Lafayette, CO
Industry:
Biotechnology
Work:
Evolutionary Genomics
Chief Science Officer
Skills:
Life Sciences
Biotechnology
Molecular Biology
Research
Product Development
R&D
Biochemistry
Cell Culture
Genomics
Data Analysis
Medical Devices
Drug Discovery
Pharmaceutical Industry
Chemistry
Fda
Walter Messier Photo 2

Walter Messier

View page

Publications

Us Patents

Methods For Producing Transgenic Plants Containing Evolutionarily Significant Polynucleotides

View page
US Patent:
6743580, Jun 1, 2004
Filed:
Jun 6, 2001
Appl. No.:
09/875666
Inventors:
Walter Messier - Longmont CO
James M. Sikela - Englewood CO
Assignee:
Evolutionary Genomics LLC - Aurora CO
International Classification:
C12Q 168
US Classification:
435 6, 435410, 435468, 436 94
Abstract:
The present invention provides methods for identifying polynucleotide and polypeptide sequences which may be associated with commercially or aesthetically relevant traits in domesticated plants or animals. The methods employ comparison of homologous genes from the domesticated organism and its ancestor to identify evolutionarily significant changes. Sequences thus identified may be useful in enhancing commercially or aesthetically desirable traits in domesticated organisms.

Methods To Identify Polynucleotide And Polypeptide Sequences Which May Be Associated With Physiological And Medical Conditions

View page
US Patent:
6866996, Mar 15, 2005
Filed:
Mar 14, 2002
Appl. No.:
10/098600
Inventors:
Walter Messier - Longmont CO, US
James Sikela - Englewood CO, US
Assignee:
Evolutionary Genomics, LLC - Aurora CO
International Classification:
C12Q001/70
C12Q001/68
US Classification:
435 5, 435 6
Abstract:
The present invention provides methods for identifying evolutionarily significant polynucleotide and polypeptide sequences in human and/or non-human primates which may be associated with a physiological condition, such as enhanced resistance to HCV infection. The invention also provides methods for identifying evolutionarily significant polynucleotides with mutations that are correlated with susceptibility to diseases, such as BRCA1 exon 11. The methods employ comparison of human and non-human primate sequences using statistical methods. Sequences thus identified may be useful as host therapeutic targets and/or in screening assays.

Methods To Identify Polynucleotide And Polypeptide Sequences Which May Be Associated With Physiological And Medical Conditions

View page
US Patent:
7247425, Jul 24, 2007
Filed:
Jun 30, 2004
Appl. No.:
10/883576
Inventors:
Walter Messier - Longmont CO, US
Assignee:
Evolutionary Genomics, LLC - Aurora CO
International Classification:
C12Q 1/68
C12Q 1/70
US Classification:
435 5, 435 6
Abstract:
The present invention provides methods for identifying evolutionarily significant polynucleotide and polypeptide sequences in human and/or non-human primates which may be associated with a physiological condition, such as enhanced resistance to AIDS infection. The invention also provides methods for identifying evolutionarily significant polynucleotides with mutations that are correlated with susceptibility to diseases, such as ICAM 1. The methods employ comparison of human and non-human primate sequences using statistical methods. Sequences thus identified may be useful as host therapeutic targets and/or in screening assays.

Eg307 Polynucleotides And Uses Thereof

View page
US Patent:
7252966, Aug 7, 2007
Filed:
Feb 19, 2002
Appl. No.:
10/079042
Inventors:
Walter Messier - Longmont CO, US
Assignee:
Evolutionary Genomics LLC - Aurora CO
International Classification:
C12Q 1/68
C07H 21/04
US Classification:
435 691, 435410, 536 236, 514 1, 800278, 800295
Abstract:
The present invention provides methods for identifying polynucleotide and polypeptide sequences which may be associated with commercially or aesthetically relevant traits in domesticated plants or animals. The methods employ comparison of homologous genes from the domesticated organism and its ancestor to identify evolutionarily significant changes and evolutionarily neutral changes. Sequences thus identified may be useful in enhancing commercially or aesthetically desirable traits in domesticated organisms or their wild ancestors.

Eg1117 Polynucleotides And Uses Thereof

View page
US Patent:
7439018, Oct 21, 2008
Filed:
Jan 16, 2003
Appl. No.:
10/345820
Inventors:
Walter Messier - Longmont CO, US
Assignee:
Evolutionary Genomics, Inc. - Lafayette CO
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present invention provides methods for identifying polynucleotide and polypeptide sequences which may be associated with commercially or aesthetically relevant traits in domesticated plants or animals. The methods employ comparison of homologous genes from the domesticated organism and its ancestor to identify evolutionarily significant changes and evolutionarily neutral changes. Sequences thus identified may be useful in enhancing commercially or aesthetically desirable traits in domesticated organisms or their wild ancestors.

Methods For Identifying Agents That Increase The P44 Function Of Microtubule Assembly Or Resistance To Hcv Infection

View page
US Patent:
7462460, Dec 9, 2008
Filed:
Feb 15, 2005
Appl. No.:
11/058065
Inventors:
Walter Messier - Longmont CO, US
James Sikela - Englewood CO, US
Assignee:
Evolutionary Genomics, Inc. - Lafayette CO
International Classification:
G01N 33/53
US Classification:
435 71
Abstract:
The present invention provides methods for identifying evolutionarily significant polynucleotide and polypeptide sequences in human and/or non-human primates which may be associated with a physiological condition, such as enhanced resistance to HCV infection. The invention also provides methods for identifying evolutionarily significant polynucleotides with mutations that are correlated with susceptibility to diseases, such as BRCA1 exon 11. The methods employ comparison of human and non-human primate sequences using statistical methods. Sequences thus identified may be useful as host therapeutic targets and/or in screening assays.

Methods To Identify Evolutionarily Significant Changes In Polynucleotide And Polypeptide Sequences In Prokaryotes

View page
US Patent:
20050181387, Aug 18, 2005
Filed:
Oct 1, 2004
Appl. No.:
10/956353
Inventors:
Walter Messier - Longmont CO, US
International Classification:
C12Q001/68
C07H021/04
US Classification:
435006000, 536023700
Abstract:
Methods for identifying polynucleotide and polypeptide sequences which may be associated with commercially relevant or useful traits in prokaryotes are provided. The methods employ comparison of homologous genes from two closely related prokaryote species to identify evolutionarily significant changes. Sequences thus identified may be useful in developing therapeutics, diagnostics, or vaccines.

Detection Of Evolutionary Bottlenecking By Dna Sequencing As A Method To Discover Genes Of Value

View page
US Patent:
20050234654, Oct 20, 2005
Filed:
Aug 8, 2003
Appl. No.:
10/522393
Inventors:
Walter Messier - Longmont CO, US
International Classification:
C12Q001/68
G06F019/00
G01N033/48
G01N033/50
US Classification:
702020000, 435006000
Abstract:
This invention relates to using molecular and evolutionary techniques to identify polynucleotide and polypeptide sequences corresponding to commercially or aesthetically relevant traits in domesticated plants and animals, specifically, a method to detect evolutionary bottleneck sequences.
Walter T Messier from Longmont, CO, age ~69 Get Report